IL96390A - Pharmaceutical compositions comprising n-alkylpiperazine-alkanamide derivatives for preventing or limiting reperfusion damage and some such novel compounds and their preparation - Google Patents

Pharmaceutical compositions comprising n-alkylpiperazine-alkanamide derivatives for preventing or limiting reperfusion damage and some such novel compounds and their preparation

Info

Publication number
IL96390A
IL96390A IL9639090A IL9639090A IL96390A IL 96390 A IL96390 A IL 96390A IL 9639090 A IL9639090 A IL 9639090A IL 9639090 A IL9639090 A IL 9639090A IL 96390 A IL96390 A IL 96390A
Authority
IL
Israel
Prior art keywords
formula
compound
aminocarbonyl
heart
amino
Prior art date
Application number
IL9639090A
Other languages
English (en)
Other versions
IL96390A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL96390A0 publication Critical patent/IL96390A0/xx
Publication of IL96390A publication Critical patent/IL96390A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Protection Of Pipes Against Damage, Friction, And Corrosion (AREA)
  • Dicing (AREA)
  • Branch Pipes, Bends, And The Like (AREA)
  • Golf Clubs (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Paper (AREA)
  • External Artificial Organs (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9639090A 1989-11-22 1990-11-19 Pharmaceutical compositions comprising n-alkylpiperazine-alkanamide derivatives for preventing or limiting reperfusion damage and some such novel compounds and their preparation IL96390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44014289A 1989-11-22 1989-11-22
SG118494A SG118494G (en) 1989-11-22 1994-08-20 Method of preventing or limiting reperfusion damage

Publications (2)

Publication Number Publication Date
IL96390A0 IL96390A0 (en) 1991-08-16
IL96390A true IL96390A (en) 1995-06-29

Family

ID=26664237

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9639090A IL96390A (en) 1989-11-22 1990-11-19 Pharmaceutical compositions comprising n-alkylpiperazine-alkanamide derivatives for preventing or limiting reperfusion damage and some such novel compounds and their preparation

Country Status (22)

Country Link
EP (2) EP0455789B1 (de)
JP (1) JP2574585B2 (de)
KR (1) KR0165686B1 (de)
AT (2) ATE213943T1 (de)
AU (1) AU632888B2 (de)
CA (1) CA2044143C (de)
CY (1) CY1869A (de)
DE (2) DE69033926T2 (de)
DK (2) DK0455789T3 (de)
ES (2) ES2173883T3 (de)
FI (1) FI109694B (de)
HK (1) HK115095A (de)
HU (1) HU215847B (de)
IE (1) IE65121B1 (de)
IL (1) IL96390A (de)
NO (2) NO304519B1 (de)
NZ (1) NZ236168A (de)
PT (2) PT95959B (de)
RU (1) RU2093156C1 (de)
SG (1) SG118494G (de)
WO (1) WO1991007967A2 (de)
ZA (1) ZA909345B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
RU2216549C2 (ru) * 1997-11-07 2003-11-20 Дайити Фармасьютикал Ко., Лтд. Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
US6573264B1 (en) * 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
KR101900124B1 (ko) 2014-06-25 2018-09-18 전남대학교산학협력단 전복 박리용 조성물
KR101644299B1 (ko) 2014-07-22 2016-08-02 주식회사 엔바이로젠 오미자 및 삼채 추출물을 유효성분으로 포함하는 전복 박리용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
NZ223847A (en) * 1987-04-01 1989-12-21 Janssen Pharmaceutica Nv Substituted piperazine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
ES2173883T3 (es) 2002-11-01
HU9102436D0 (en) 1991-12-30
FI109694B (fi) 2002-09-30
JP2574585B2 (ja) 1997-01-22
IE904209A1 (en) 1991-05-22
NO912511L (no) 1991-08-26
DK0577171T3 (da) 2002-06-03
CA2044143C (en) 2002-11-19
HUT58709A (en) 1992-03-30
ES2053208T3 (es) 1994-07-16
FI913433A0 (fi) 1991-07-16
SG118494G (en) 1994-11-25
NO912511D0 (no) 1991-06-26
EP0455789A1 (de) 1991-11-13
DE69033926D1 (de) 2002-04-11
DE69033926T2 (de) 2002-10-24
NO311701B1 (no) 2002-01-14
NO304519B1 (no) 1999-01-04
EP0577171A2 (de) 1994-01-05
DE69007471T2 (de) 1994-06-23
DE69007471D1 (de) 1994-04-21
IL96390A0 (en) 1991-08-16
PT95959B (pt) 1998-08-31
AU632888B2 (en) 1993-01-14
AU6876391A (en) 1991-06-26
PT102145B (pt) 2002-06-28
WO1991007967A2 (en) 1991-06-13
KR920700644A (ko) 1992-08-10
ZA909345B (en) 1992-08-26
PT102145A (pt) 1999-10-29
NO982078D0 (no) 1998-05-07
CY1869A (en) 1996-04-05
KR0165686B1 (ko) 1999-01-15
ATE102831T1 (de) 1994-04-15
EP0577171A3 (en) 1994-06-29
EP0455789B1 (de) 1994-03-16
PT95959A (pt) 1991-09-13
DK0455789T3 (da) 1994-04-05
HK115095A (en) 1995-07-21
NZ236168A (en) 1993-05-26
WO1991007967A3 (en) 1991-07-11
ATE213943T1 (de) 2002-03-15
HU215847B (hu) 1999-04-28
NO982078L (no) 1991-08-26
CA2044143A1 (en) 1991-05-23
EP0577171B1 (de) 2002-03-06
RU2093156C1 (ru) 1997-10-20
IE65121B1 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
AU632888B2 (en) Use of piperazine acetamide derivatives against reperfusion damage
JP4352613B2 (ja) 血管新生促進剤及び血管新生作用増強剤
US5030644A (en) Imidazole compounds and their use as transglutaminase inhibitors
PL187000B1 (pl) Nowe związki, podstawione piperazynometylo-oksazolidynony, sposób ich wytwarzania i ich zastosowanie oraz preparat farmaceutyczny
JPH04503524A (ja) 再潅流損傷の防止又は制限のための薬剤
US5098707A (en) Imidazole compounds and their use as transglutaminase inhibitors
US5840896A (en) Method of preventing or limiting reperfusion damage
PL183595B1 (pl) Nowe związki, pochodne oksazolidynonu i sposób ich wytwarzania oraz preparat farmaceutyczny
EP0682947A1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
CZ300365B6 (cs) Inhibitory faktoru VIIa, zpusob jejich prípravy a jejich použití
JPH029894A (ja) ニツコマイシン誘導体とアゾールからなる抗真菌剤
US5753667A (en) 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
US4693996A (en) Method of treating heart failure and medicaments therefor
IE19950407A1 (en) Use of piperazine acetamide derivatives against reperfusion damage
IE83628B1 (en) Topical compositions comprising benzimidazoles and benzotriazoles
US5602123A (en) Therapeutic agent for myocardial ischemic damages or reperfusion
JPH07118262A (ja) 新規１，２−ジチオール−３−チオン誘導体
JP2005314348A (ja) 顔面神経麻痺治療剤
US5416120A (en) Vascular hypertrophy inhibitor
WO2003067979A1 (fr) Medicaments destines a etre utilises dans la transplantation d'organes
EP0284925A2 (de) Verwendung von Imidazol-2-thionen zur Herstellung eines Arzneimittels zur Verringerung von 'Stunning' des Myokardiums
CA2989767A1 (en) Combination of tafia inhibitor with plasminogen activator
JP2018080113A (ja) 脳梗塞処置剤
CA2022116A1 (en) Imidazole compounds and their use as transglutaminase inhibitors
JP2004346067A (ja) 抗血栓薬の治療可能時間を延長するための薬剤

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees